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Summary
The “BH3-only” proapoptotic BCL-2 family members
are sentinels of intracellular damage. Here, we dem-
onstrated that the BH3-only BID protein partially lo-
calizes to the nucleus in healthy cells, is important
for apoptosis induced by DNA damage, and is phos-
phorylated following induction of double-strand
breaks in DNA. We also found that BID phosphoryla-
tion is mediated by the ATM kinase and occurs in
mouse BID on two ATM consensus sites. Interest-
ingly, BID−/− cells failed to accumulate in the S phase
of the cell cycle following treatment with the topo-
isomerase II poison etoposide; reintroducing wild-
type BID restored accumulation. In contrast, introduc-
ing a nonphosphorylatable BID mutant did not restore
accumulation in the S phase and resulted in an in-
crease in cellular sensitivity to etoposide-induced
apoptosis. These results implicate BID as an ATM ef-
fector and raise the possibility that proapoptotic BID
may also play a prosurvival role important for S
phase arrest.
Introduction
The BH3-only proteins are sentinels of intracellular
damage (Puthalakath and Strasser, 2002). These pro-
teins are held in check by diverse mechanisms, seem-
ingly at cellular locations at which they can sense spe-
cific damage.
BID is believed to be relatively inactive in the cytosol
until proteolytically cleaved by caspase-8. Cleavage of
cytosolic BID at Asp59 yields a p15 C-terminal trun-
cated fragment (tBID) that translocates to the mito-
chondria, where it induces the activation of BAX and
BAK, resulting in the release of cytochrome c (Wang,
2001). Phosphorylation seems to regulate BID activity,
since it was recently demonstrated that its phosphory-*Correspondence: atan.gross@weizmann.ac.il
4 These authors contributed equally to this work.lation by casein kinase 1 and/or 2 inhibits its cleavage
by caspase-8 (Desagher et al., 2001).
However, the apoptotic pathways in which BID plays
a role are not yet fully characterized. Studies with BID−/−
mice have demonstrated that BID is required for Fas-
induced apoptosis (Yin et al., 1999). On the other hand,
BID−/− mouse embryonic fibroblasts (MEFs) were found
to be as susceptible as BID+/+ MEFs to a wide range of
intrinsic damage signals (Wei et al., 2001). More re-
cently, however, it was demonstrated that BID−/− MEFs
are less susceptible than BID+/+ MEFs to the DNA-dam-
age reagent adriamycin, as well as to the nucleotide
analog 5-fluorouracil (Sax et al., 2002). Thus, BID may
contribute to the DNA-damage response.
In eukaryotes, each cell’s genetic material is con-
stantly subjected to DNA damage. While a double-
strand break (DSB) is not the major DNA lesion, it is
certainly among the most harmful. Following DSBs, the
cell may activate a survival system that enables repair
and continuation of its normal life cycle, or it may acti-
vate its apoptotic machinery in the face of extensive or
irreparable damage (Kaina, 2003).
One of the major responses associated with the cell-
survival network is the temporary arrest of cell cycle
progression, which reflects the activation of cell cycle
checkpoints (Iliakis et al., 2003). The best-documented,
damage-induced cell cycle checkpoints operate in the
G1/S boundary and at the S and G2 phases. The very
early events that take place at the site of a DNA double-
strand break and precede activation of the response
network involve several proteins that are rapidly re-
cruited to the damaged site; there, they act as DSB
sensors. They then convey a damage signal to trans-
ducers, which in turn deliver it to numerous down-
stream effectors.
A prototype transducer of the DSB response is ATM,
a nuclear serine-threonine protein kinase which is
absent or inactivated in patients with the genomic in-
stability syndrome ataxia-telangiectasia (A-T) (Shiloh,
2003). Cells from A-T patients exhibit genomic instabil-
ity, radiosensitivity, and defective activation of the en-
tire DSB response, most notably, the cell cycle check-
points. ATM is a member of a group of conserved large
proteins, several of which are protein kinases involved
in mediating DNA-damage responses. These proteins
(including ATR [ATM and RAD3-related]) share several
motifs, among them a domain containing a PI3-kinase
signature, which gives this group the title, “PI3-kinase-
related protein kinases” (PIKKs). Activated ATM phos-
phorylates a wide spectrum of substrates, many of
them at the sites of damage. The functional conse-
quences of some of ATM phosphorylation events have
been associated with the activation of the cell cycle
checkpoints. However, not all of the phenotypic abnor-
malities in A-T patients and their cells can be explained
by a lack of these phosphorylation events, implying that
additional ATM targets exist, which have not yet been
identified.
Previously, we suggested that full-length BID is a
player in the DNA-damage pathway, since a caspase-8
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bryonic fibroblasts (MEFs) to DNA damage-induced
apoptosis (Sarig et al., 2003). Our current findings de-
monstrate that BID is partially localized to the nucleus
in healthy MEFs and is important for apoptosis induced
by a variety of DNA-damaging reagents. Moreover, we
show that etoposide and ionizing radiation, both of
which are known to induce double-strand breaks in
DNA, lead to the phosphorylation of BID. Our findings
indicate that BID phosphorylation is mediated by the
ATM kinase, and occurs in mouse BID on two ATM con-
sensus sites (S61Q and S78Q). We also found that eto-
poside induced accumulation of BID+/+ MEFs in the S
and G2 phases of the cell cycle, whereas such an accu-
mulation was not observed in the BID−/− MEFs. Reintro-
ducing wild-type BID into BID−/− cells restored their
ability to accumulate in the S and G2 phases, whereas
introducing a nonphosphorylatable BID mutant (S61A/
S78A) restored accumulation in the G2 phase but not in
the S phase. Moreover, in response to etoposide, the
mutant BID cells entered apoptosis more readily than
did the wild-type BID cells. These results implicate BID
as an ATM effector and raise the novel possibility that
BID, a molecule that was previously considered to be
active only as a proapoptotic factor, may also play a
prosurvival role important for S phase arrest.
Results
BID Is Important for DNA
Damage-Induced Apoptosis
To determine whether BID is required for DNA damage-
induced apoptosis, we generated hTERT-immortalized
BID+/+ and BID−/− mouse embryonic fibroblasts and an-
alyzed their response to a variety of DNA-damaging
reagents: etoposide (Etop; a specific inhibitor of topo-
isomerase II), cisplatin (Cis; forms covalent adducts
with the DNA), ultraviolet radiation (UV; induces thy-
mine dimers), and ionizing radiation (IR). We found that
BID−/− MEFs were less susceptible than BID+/+ MEFs to
all four treatments (Figure 1A). These DNA-damaging
reagents also induced less cell death in primary BID−/−
MEFs than in primary BID+/+ MEFs (data not shown),
confirming that this decreased sensitivity is not due to
hTERT immortalization. Splenocytes from BID−/− mice
also display less susceptibility to Etop treatment (see
Figure S1A in the Supplemental Data available with this
article online), indicating that the decreased death re-
sponse to DNA damage is a general feature of BID defi-
ciency, although it is more pronounced in MEFs.
To confirm that BID−/− MEFs are indeed less sensitive
than BID+/+ MEFs to DNA damage-induced cell death,
we performed clonogenic survival assays with MEFs
following DNA damage. Our studies show that BID−/−
MEFs have increased clonogenic survival following IR
and Etop treatment (Figure 1B and data not shown). We
have also created MEFs that are more sensitive to DNA
damage-induced cell death by transforming primary
BID+/+ and BID−/− MEFs with the SV40 whole genome.
Cell death assays with these cells using much lower
levels of DNA-damaging reagents confirmed that BID
loss reduces sensitivity to DNA damage-induced cell
death (Figure S1B). Finally, to confirm that the reduced
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1usceptibility of BID−/− MEFs to DNA-damaging re-
gents was due to the absence of BID, BID−/− MEFs
ere infected with recombinant adenoviruses carrying
he BID vector prior to treatment with Etop or IR. The
esults show that reintroduction of BID did not induce
ell death on its own but fully restored susceptibility to
top- (and partially to IR)-induced cell death (Figure 1C).
NA-Damaging Reagents Causing Double-Strand
reaks Induce the Phosphorylation of BID, and This
hosphorylation Is Mediated by the ATM Kinase
ext, we explored whether BID was modified in re-
ponse to DNA damage. Western blot analysis using
nti-BID antibodies on lysates of hTERT-immortalized
ID+/+ MEFs treated with the DNA-damaging reagents
entioned above revealed that Etop and IR, which are
nown to induce DSBs in DNA, unlike Cis or UV, in-
uced a double electrophoretic mobility shift in BID
Figure 2A, note that the lower of the two shifted bands
oes not separate well from the regular BID band). We
lso treated MEFs with several other apoptotic re-
gents: thapsigargin (Thaps; stress signaling from the
R, which inhibits the Ca2+ adenosine triphosphate
ump); TNFα together with actinomycin D; or with
taurosporine (STS; a kinase inhibitor) and found that
one of them affected the electrophoretic mobility of
ID (Figure 2A). Etop and IR induced a similar double
lectrophoretic mobility shift in BID also in primary
ID+/+ MEFs (data not shown), confirming that this shift
s not due to hTERT immortalization. Similar mobility
hifts have been associated with covalent modifica-
ions of proteins, for example, as a consequence of
hosphorylation.
To define whether the double electrophoretic mobility
hift in BID was due to phosphorylation, BID+/+ MEFs
ere treated with Etop for 30 min, lysed, and either left
ntreated or incubated with alkaline phosphatase for
0 min at 37°C. Western blot analysis using anti-BID
ntibodies demonstrated that treatment with alkaline
hosphatase abolished the electrophoretic mobility
hifts in BID (Figure 2B), indicating that these shifts are
ost likely due to phosphorylation. Taken together,
hese results strongly suggest that BID is rapidly phos-
horylated in response to reagents that induce double-
trand breaks in DNA.
To confirm that BID was phosphorylated, human cer-
ical adenocarcinoma (HeLa) cells were transfected
ith mouse BID, labeled with 32P-orthophosphate, either
eft untreated or treated with Etop, and BID-immuno-
recipitated. Exposure to Etop resulted in a marked in-
rease in 32P-labeling of BID, which appeared as a
oublet (Figure 2C, left). Western blot analysis of the
ame samples with anti-BID antibodies indicated that
he two 32P-labeled bands correspond to the two
lower-migrating forms of BID (Figure 2C, right).
The ATM kinase plays a pivotal role in the immediate
esponse of cells to double-strand breaks. To deter-
ine whether ATM is involved in the phosphorylation of
ID, we utilized mouse embryonic fibroblasts deficient
n both ATM and the p19ARF tumor-suppressor gene,
ince loss of ARF has been shown to reverse premature
eplicative arrest of ATM-deficient MEFs (Kamijo et al.,
999). Accordingly, ATM/ARF double-knockout MEFs,
BID Is an ATM Effector
595Figure 1. BID Is Important for DNA Damage-
Induced Apoptosis
(A) BID−/− MEFs are less susceptible than
BID+/+ MEFs to apoptosis induced by DNA-
damaging reagents. Dose-response/death
curves of BID+/+ and BID−/− MEFs in re-
sponse to treatment with the indicated
doses of Etop (24 hr), Cis (14 hr), UV (14 hr),
and IR (24 hr). Cell death was monitored by
FACScan using PI dye exclusion, as de-
scribed in the Experimental Procedures. The
data shown represent the means ±SEM of
pooled results from three independent ex-
periments.
(B) BID−/− MEFs have increased clonogenic
survival compared to BID+/+ cells following
DNA damage. One thousand cells from BID+/+
and BID−/− MEFs were seeded per well and
irradiated with the indicated doses of IR.
Cells were then incubated for 10 days and
the percent of colony survival was calcu-
lated as the ratio of the number of colonies
formed after IR to the number of colonies
formed in untreated cells. * represent signifi-
cant differences (p < 0.05) based on Stu-
dent’s t test.
(C) The reduced susceptibility of BID−/−
MEFs to DNA-damaging reagents is due to
the absence of BID. BID+/+ or BID−/− MEFs were either left untreated (N/T) or treated with either Etop (100 M; 24 hr; left) or ionizing radiation
(IR; 100 Gy; 24 hr; right), and cell death was monitored by FACScan using PI dye exclusion. Alternatively, BID−/− MEFs were infected with
recombinant adenoviruses carrying a tetracycline-inducible BID vector. Two hours after the addition of doxycyclin, the cultures were washed
three times and treated with either Etop or IR. Cell death was monitored as described above. The data represent the means ±SEM of pooled
results from three independent experiments.as well as Atm+/+Arf−/− MEFs, were treated with Etop or
IR and Western blot analyzed using anti-BID antibod-
ies. Figure 2D shows that following Etop or IR treat-
ment, the slower migrating bands of BID do not appear
in the ATM-deficient cells. Thus, the presence of the
ATM kinase appears to play an essential role in the pro-
cess by which etoposide and ionizing radiation induce
phosphorylation of BID.
To corroborate these findings, we took advantage of
a stable HeLa cell line in which ATM was knocked down
by siRNA (in these cells, the level of ATM was reduced
byw95% [Elkon et al., 2005]). Both these cells and the
control cells, which carried a siRNA against LacZ, were
transfected with mouse BID, exposed to Etop, and
Western blot analyzed using anti-BID antibodies. Expo-
sure of control HeLa cells to Etop induced a double
electrophoretic mobility shift in BID that was absent in
the ATM knocked-down cells (Figure 2E, left and middle
panels). BID−/− MEFs were used as a specificity control
(Figure 2E, right panel). These results further confirm
that the presence of ATM is essential for BID phosphor-
ylation.
Mouse and Human BID Are Phosphorylated
on PIKK Consensus Sites
As mentioned in the Introduction, ATM is a member of
the PIKK family. The common phosphorylation sites for
PIKKs are serines or threonines followed by glutamine
residues, a motif commonly dubbed “SQ/TQ” (Kim et
al., 1999). Mouse BID carries two such motifs (S61Q and
S78Q), whereas human and rat BID carry only one (S78Q;
Figure 3A).
To determine whether mouse BID is phosphorylatedon one or both of these sites, we mutated each of these
serines to alanines. Our initial analysis was performed
in HeLa cells transfected with either wild-type (wt) BID
or transfected with one or the other of the BID mutants.
Western blot analysis using anti-BID antibodies indi-
cated that treatment of the aforementioned cells with
Etop resulted in a double electrophoretic mobility shift,
which was abolished in the S61A mutant (Figure 3B). In
contrast, mutating the S78 site had no effect on the
appearance of the two slower-migrating bands. Thus,
BID phosphorylation on S61 is likely the cause for the
electrophoretic mobility shift.
To confirm the results presented above and to estab-
lish whether serine 78 is also phosphorylated in mouse
BID in response to Etop, we generated phosphospe-
cific antibodies to serine 61 and serine 78 (see Experi-
mental Procedures). We initially performed Western
blot analysis with these antibodies on lysates of mouse
embryonic fibroblasts. To define whether these anti-
bodies recognize the phosphorylated form of BID, BID+/+
MEFs were either not treated or treated with Etop for
30 min, lysed, and either left untreated or incubated
with potato-acid phosphatase for 30 min at 37°C. West-
ern blot analysis demonstrated that anti-pS61 antibod-
ies recognized a band of the expected size of BID in
Etop-treated cells and that treatment with potato-acid
phosphatase abolished this recognition (Figure 3C, left;
note that these antibodies recognize an additionalw30
kDa protein that shares antigenicity with pS61-BID).
Western blot analysis using the anti-pS78 antibodies
demonstrated that these antibodies recognized three
bands (one strong band and two very faint bands) in
Etop-treated cells; treatment with potato-acid phos-
Cell
596Figure 2. DNA-Damaging Reagents Causing Double-Strand Breaks Induce the Phosphorylation of BID, and This Phosphorylation Is Mediated
by the ATM Kinase
(A) Etop and IR induce a double electrophoretic mobility shift in BID. BID+/+ MEFs were either left untreated (N/T) or treated with one of the
indicated cell death stimuli: Etop (100 M), IR (50 Gy), Cis (50 M), UV (20 J/m2), Thaps (2 mM), TNFα (40 ng/ml together with 2 g/ml
actinomycin D), and STS (4 M). Cells were collected 1 hr later, lysed, and equal amounts of protein (20 g per lane) were subjected to SDS-
PAGE, followed by Western blot analysis using anti-BID Abs. The blot was stripped and reprobed with anti-β-actin Abs to control for loading
(lower panel). * marks a crossreactive band. The question mark marks the BID double electrophoretic mobility shift.
(B) Alkaline phosphatase treatment abolishes the Etop-induced double electrophoretic mobility shift in BID. BID+/+ MEFs were treated with
100 M Etop for 30 min, lysed, and either left untreated (−), or treated with alkaline phosphatase (+) for 30 min at 37°C, followed by Western
blot analysis using anti-BID Abs. BID-P marks the BID double electrophoretic mobility shift.
(C) Exposure to Etop results in a marked increase in 32P-labeling of BID, which appears as a doublet. HeLa cells were transiently transfected
with pcDNAIII-wtBID. Eighteen hours posttransfection, cells were metabolically labeled with 32P-orthophosphate and later, either left untreated
(−), or treated with 100 M Etop for 30 min. Radiolabeled BID was immunoprecipitated with anti-BID Abs and evaluated by either autoradiogra-
phy (left) or by Western blot, using anti-BID Abs (right).
(D) The slower-migrating forms of BID do not appear in ATM-deficient MEFs. ATM/ARF double-knockout MEFs (Atm−/−) and Atm+/+Arf−/−
MEFs (Atm+/+) were either left untreated (N/T) or treated with 100 M Etop or 50 Gy IR, collected after 30 min, and lysed. Equal amounts of
protein (20 g per lane) were subjected to SDS-PAGE, followed by Western blot analysis using anti-BID Abs. The blot was stripped and
reprobed with anti-β-actin Abs to control for loading (lower panel).
(E) Etop-induced phosphorylation of exogenous BID is detected in LacZ, but not in ATM knocked-down HeLa cells. Left panel: HeLa cells
were transiently transfected with pcDNAIII-wtBID. Eighteen hours posttransfection, cells were either left untreated (−) or treated with 100 M
Etop for 30 min, collected, lysed, and Western blot analyzed using anti-BID Abs. Middle panel: stable LacZ knocked-down and stable ATM
knocked-down HeLa cells were transfected with pcDNAIII-wtBID, treated with Etop, and analyzed as described for the left panel. Right panel:
BID−/− MEFs treated with Etop for 30 min were used as a specificity control for the anti-BID Abs. All blots shown in (E) were stripped and
reprobed with anti-β-actin Abs to control for loading (lower panels).phatase abolished all three bands (Figure 3C, right).
The bands identified with both antibodies corres-
ponded to BID, since they were not identified in BID−/−
MEFs (Figure 3C).
Next, we determined whether mutation of either ser-
ine 61 or serine 78 to alanine abolished recognition of
mouse BID by the phosphospecific antibodies. These
experiments were performed in HeLa cells transfected
with either wtBID, the BID-S61A mutant, or the BID-
S78A mutant. The anti-pS61 and anti-pS78 antibodies
recognized BID in cells expressing wtBID and treated
with Etop, but not in cells expressing the BID-S61A or
BID-S78A mutant, respectively (Figure S2A).
To determine if ATM (and possibly ATR) could directly
phosphorylate BID, we performed in vitro kinase assays
using flag-tagged human ATM and ATR (and the kinase-
inactive forms) and purified recombinant mouse wtBID
and the BID-S61A/S78A double mutant. Wild-type but
not kinase-inactive human ATM and ATR efficiently
phosphorylate recombinant wtBID in vitro, whereas
mutating both S61 and S78 completely abolished BID
phosphorylation (Figure S2B). Taken together, these
data indicate that BID is a substrate of both ATM and
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wTR in vitro and that S61 and/or S78 are the sites phos-
horylated by these kinases.
To determine whether BID is phosphorylated in an-
ther cell type, we have examined the phosphorylation
tatus of BID in mouse splenocytes either not treated
r treated with Etop. As shown in Figure S2C, Etop in-
uces the phosphorylation of BID on both S61 and S78
n splenocytes.
As mentioned above, human BID carries only one
IKK consensus site (S78; Figure 3A). To determine
hether endogenous human BID is phosphorylated on
78, we performed Western blot analysis with anti-
uman BID and anti-pS78 antibodies on lysates of
EK293 cells either not treated or treated with Etop.
he anti-pS78 antibodies recognized a band of the size
f human BID only in cells treated with Etop (Figure
2D). To confirm these results, we cloned human BID,
enerated a human BID-S78A mutant, and expressed
ither the wild-type or the mutant BID in HeLa cells.
estern blot analysis using anti-pS78 antibodies
howed an increase in the intensity of the band that
epresents phosphorylated BID in cells transfected with
ild-type human BID but not in cells transfected with
BID Is an ATM Effector
597Figure 3. Mouse BID Is Phosphorylated on Serine 61 and Serine 78
(A) Mouse BID carries two PIKK consensus sites (S61Q and S78Q), whereas human and rat BID carry only one (S78Q).
(B) Mutation of serine 61 to alanine abolishes the Etop-induced double electrophoretic mobility shift in BID. HeLa cells were transiently
transfected with pcDNAIII-wtBID, pcDNAIII-BID-S61A, pcDNAIII-BID-S78A or left untransfected (−). Eighteen hours posttransfection, cells
were either left untreated (−) or treated with 100 M Etop for 30 min, collected, lysed, and Western blot analyzed using anti-BID Abs. The
blot was stripped and reprobed with anti-β-actin Abs to control for loading (lower panel).
(C) The phosphospecific antibodies to serine 61 and serine 78 recognize endogenous BID in MEFs treated with Etop. BID+/+ or BID−/− MEFs
were either left untreated (−) or treated with 100 M Etop for 30 min (+), lysed, and Western blot analyzed using the phosphospecific Abs to
either S61 (left) or S78 (right). Alternatively, BID+/+ MEFs treated with 100 M Etop for 30 min were collected, treated with potato acid
phosphatase (PAP; +) for 30 min at 37°C, lysed and Western blot analyzed as above. The blots were stripped and reprobed with anti-β-actin
Abs to control for loading (lower panels). BID-P marks the phosphorylated form of BID. * marks a crossreactive band.
(D) Time course of Etop-induced phosphorylation of endogenous mouse BID on S61 and S78. BID+/+ MEFs were either left untreated (N/T) or
treated with 100 M Etop, collected at the indicated time points, lysed, and equal amounts of protein (20 g per lane) were subjected to
SDS-PAGE followed by Western blot analysis using either anti-BID (top), anti-pS61 (middle top), or anti-pS78 (middle bottom) Abs. The blot
was stripped and reprobed with anti-β-actin Abs to control for loading (bottom). * marks a crossreactive band.
(E) Time course of Etop-induced apoptosis of MEFs. BID+/+ MEFs were treated with 100 M Etop, collected at the indicated time points, and
cell death was monitored as described in the Experimental Procedures.
(F) Mouse BID is phosphorylated on S61 only in response to reagents that induce double-strand breaks in DNA. BID+/+ MEFs were either left
untreated (N/T) or treated with the death stimuli indicated in Figure 2A. Cells were collected 1 hr later, lysed, and equal amounts of protein
(20 g per lane) were subjected to SDS-PAGE followed by Western blot analysis using anti-pS61 Abs (top). The blot was stripped and
reprobed with anti-β-actin Abs to control for loading (bottom). * marks a crossreactive band.the BID-S78A mutant (Figure S2E). Thus, human BID is
phosphorylated on S78 in response to Etop.
Phosphorylation of Serine 61 and Serine 78
Is Transient, ATM Dependent, and Only
Occurs in Response to Reagents that
Induce Double-Strand Breaks
To determine the time course of endogenous mouse
BID phosphorylation, BID+/+ MEFs were treated with
Etop and Western blot analyzed with the anti-BID, the
anti-pS61, or the anti-pS78 antibodies. Phosphoryla-
tion of S61 was detected by 15 min (the first time point
analyzed), reached a peak at 1 hr, and was reduced by
3 hr post-Etop treatment (Figure 3D). Phosphorylation
of S78 was also transient (peak at 2–3 hr), though was
somewhat delayed, compared to phosphorylation of
the S61 site.
Next, we determined when apoptosis began in MEFstreated with Etop and found that the onset of apoptosis
occurred between 8 and 12 hr following Etop treatment
(Figure 3E). Thus, BID phosphorylation occurs many
hours prior to the onset of apoptosis.
To determine whether endogenous mouse BID is
phosphorylated on S61 and S78 in an ATM-dependent
manner, we utilized the phosphospecific antibodies for
Western blot analysis of ATM/ARF double-knockout
and Atm+/+Arf−/− mouse embryonic fibroblasts either
not treated or treated with Etop. This analysis demon-
strated that endogenous mouse BID is phosphorylated
on S61 and S78 only in Atm+/+Arf−/− MEFs treated with
Etop (Figure S3A).
To show that phosphorylation of mouse BID was spe-
cific for reagents inducing double-strand breaks, we
treated mouse embryonic fibroblasts with several DNA-
damaging and other apoptotic reagents (previously de-
scribed in Figure 2). Posttreatment, cells were lysed,
Cell
598and the phosphorylation of endogenous mouse BID
was examined by Western blot analysis using anti-
pS61 antibodies. The results demonstrated that mouse
BID is phosphorylated on S61 only in response to re-
agents that induce double-strand breaks (Figure 3F).
Finally, to define whether phosphorylation of human
BID was also ATM-dependent and occurred only in re-
sponse to reagents that induce double-strand breaks,
we took advantage of a stable HEK293 cell line in which
ATM was knocked down by siRNA (these cells were
generated like the HeLa ATM knocked-down cells [El-
kon et al., 2005]). These cells and the control cells,
which carried a siRNA against LacZ, were exposed to
Etop, IR, UV, or STS, and Western blot analyzed using
anti-pS78 antibodies. Exposure of LacZ knocked down
cells to Etop or IR, but not to UV or STS, induced phos-
phorylation of endogenous human BID on serine 78,
which did not occur in the ATM knocked-down cells
(Figure S3B).
Cellular BID Partially Localizes to the Nucleus,
and Its Phosphorylation Occurs Very Rapidly,
in Response to Extremely Low, Nonapoptotic
Levels of Ionizing Radiation
Next, we analyzed the cellular location of BID and its
phosphorylated form. To determine the location of BID
in healthy cells, we performed immunofluoresence
studies with BID+/+ and BID−/− MEFs using anti-BID an-
tibodies. Surprisingly, in these studies we obtained
positive staining of BID in the nucleus (Figure 4A, left
top panels). These antibodies specifically recognized
BID, since we obtained very low staining in BID−/− MEFs
(Figure 4A, right top panels). To determine whether Etop
treatment leads to a change in the staining pattern of
BID, BID+/+ and BID−/− MEFs were treated with Etop for
3 hr prior to fixation. These studies have indicated that
Etop did not change the staining pattern of BID (Figure
4A, bottom panels).
To assess whether BID indeed localizes to the nu-
cleus in healthy MEFs, we have performed subcellular
fractionations followed by Western blotting using anti-
BID antibodies. In these experiments, cellular BID was
detected only in the soluble/cytoplasmic fraction (Fig-
ure 4B, left top panel). MEK and BAX (cytosolic pro-
teins) and lamin B (a nuclear protein) were used as
markers to confirm the purity of the nuclear/cytoplas-
mic fractions (Figure 4B, left bottom panels). These re-
sults, together with the immunofluoresence results,
suggested that BID might be loosely associated with
the nuclear fraction and that cellular disruption leads
to its dissociation from this fraction. To examine this
possibility, cells were treated with formaldehyde as a
crosslinker prior to cellular disruption. These experi-
ments demonstrated that a small fraction of cellular
BID was localized to the nuclear fraction (Figure 4B,
right panels). These results suggest that BID is loosely
associated with the nuclear fraction by interaction with
another protein(s) and that crosslinking is required to
preserve this interaction. To determine whether Etop
treatment leads to a change in the levels of nuclear BID,
cells were treated with Etop for 1 and 3 hr and then
treated with formaldehyde followed by subcellular frac-
tionation. We found that Etop did not change the levels
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iigure 4. Mouse BID Is Partially Localized to the Nucleus, and Its
hosphorylation Occurs Very Rapidly, in Response to Extremely
ow, Nonapoptotic Levels of Ionizing Radiation
A) Positive staining of BID in the nucleus of healthy MEFs. BID+/+
EFs (left) or BID−/− MEFs (right) grown on glass coverslips, were
ither left untreated (top four panels) or treated with 100 M Etop
or 3 hr (bottom four panels), fixed, and immunostained with anti-
ID Abs (green), as described in the Experimental Procedures. The
uclei were visualized by DAPI staining (blue).
B) A small fraction of cellular BID is detected in the nuclear frac-
ion. BID+/+ MEFs were either left untreated (−) or treated with form-
ldehyde (+) and subfractionated as described in the Experimental
rocedures. Aliquots of the cytosolic (C) and nuclear (N) fractions
ere subjected to SDS-PAGE followed by Western blot analysis
sing anti-BID (top), anti-MEK (middle top), anti-BAX (middle bot-
om), and anti-lamin B (bottom) Abs. * marks a crossreactive band
hat might represent a modified form of BID.
C) Phosphorylation of BID occurs very rapidly following IR. BID+/+
EFs were either left untreated (N/T) or treated with 50 Gy IR, col-
ected 5 min later, and lysed. Equal amounts of protein (20 g per
ane) were subjected to SDS-PAGE followed by Western blot analy-
is using either anti-BID Abs (top) or anti-pS61 Abs (middle). The
lot was stripped and reprobed with anti-β-actin Abs to control for
oading (bottom).
D) Phosphorylation of BID occurs in response to extremely low,
onapoptotic levels of IR. BID+/+ or BID−/− MEFs were either left
ntreated (N/T) or treated with the indicated doses of IR, collected
0 min later, lysed, and analyzed as described in (C).f BID associated with the nuclear fraction (data not
hown).
To determine the cellular location of the phosphory-
ated forms of BID, we performed immunofluoresence
tudies with the phosphospecific antibodies using
ID+/+ and BID−/− MEFs either not treated or treated
ith Etop for 30 min. These antibodies detected an in-
rease in nuclear fluorescence in BID+/+ MEFs treated
ith Etop; however, a similar increase was detected in
ID−/− MEFs (data not shown). Thus, these antibodies
rossreact with other phospho-S/T-Q proteins. None-
heless, the fact that BID partially localizes to the nu-
leus and that all currently identified substrates of ATM
re nuclear proteins, suggests that BID is phosphory-
ated in the nucleus.
To assess whether BID might be involved in the
mmediate cellular response to DNA damage, we next
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599determined the earliest point at which BID in mouse
embryonic fibroblasts was phosphorylated, following
exposure to ionizing radiation. Phosphorylation of ser-
ine 61 was detectable immediately after exposing cells
to 50 Gy IR (Figure 4C).
We previously determined that phosphorylation of
BID on both serine 61 and serine 78 occurs several
hours prior to the onset of apoptosis (Figure 3). We
therefore speculated that phosphorylation might also
occur in response to extremely low levels of ionizing
radiation which do not result in apoptosis. Indeed, we
determined that a 25-fold lower dose of IR (0.2 Gy) was
sufficient to induce phosphorylation of BID (Figure 4D).
BID−/− Mouse Embryonic Fibroblasts Fail to
Accumulate in the S and G2 Phases of the
Cell Cycle Following Etoposide Treatment
The functional consequences of certain ATM phosphor-
ylation events include activation of cell cycle check-
points, which result in temporary arrest of cell cycle
progression to enable DNA repair (Iliakis et al., 2003).
The best-documented, damage-induced cell cycle
checkpoints operate in the G1/S boundary and at the S
and G2 phases. To examine the possible involvement
of BID in cell cycle arrest following DNA double-strand
breaks, we performed cell cycle analyses on BID+/+ and
BID−/− mouse embryonic fibroblasts either not treated
or treated with etoposide. Etop induced accumulation
of BID+/+ MEFs in the S and G2 phases of the cell cycle
(as measured 8 hr after release into drug-free medium),
whereas such an accumulation was not observed in the
BID−/− MEFs (Figure 5A). These results suggest that BID
is important for the accumulation of cells in the S and
G2 phases of the cell cycle following double-strand
break DNA damage.
To determine whether BID is required for S phase ar-
rest following DNA damage, we performed double-
labeling experiments with BrdU and PI to determine the
level of DNA synthesis and to follow the progress of
cells through S phase after Etop treatment. The results
demonstrate that BID+/+ MEFs show a decrease in DNA
synthesis (less BrdU-positive cells), whereas BID−/−
MEFs fail to show a decrease in DNA synthesis (Figure
5B). Moreover, BID−/− MEFs are not delayed in their pro-
gression form S to G2/M (Figure 5C). Taken together,
these experiments prove that BID−/− MEFs fail to arrest
in S phase following Etop treatment.
BID−/− Mouse Embryonic Fibroblasts Expressing
a Nonphosphorylatable BID Mutant (S61A/S78A)
Do Not Accumulate in the S Phase
Following Etoposide Treatment
To assess whether ATM-mediated phosphorylation is
regulating BID’s function in this process, we generated
BID−/− single stable clones expressing either wtBID or
a nonphosphorylatable BID mutant (S61A/S78A). We
initially confirmed that wtBID (in the wtBID clones) was
phosphorylated on S61 and S78 in response to Etop
and that BID-S61A/S78A (in the mutant BID clones) was
not (Figure 6A).
Next, we performed cell cycle analysis on two of the
wtBID and two of the BID-S61A/S78A stable clones. As
shown in Figure 6B, Etop induced accumulation of thewtBID clones in the S and G2 phases of the cell cycle
(as measured 8 hr after release into drug-free medium),
whereas the mutant BID clones bypassed accumula-
tion in the S phase and rapidly accumulated in the G2
phase. Thus, the mutant BID cells were found to be
impaired in their ability to temporarily arrest in S phase
following double-strand break DNA damage.
BID−/− Mouse Embryonic Fibroblasts Expressing
BID-S61A/S78A Are More Susceptible to Etop-
Induced Apoptosis Than Those Expressing
Wild-Type BID
To explore a possible connection between BID phos-
phorylation, cell cycle progression, and apoptosis, we
assessed the levels of apoptosis in the two wtBID and
in the two BID-S61A/S78A clones either not treated or
treated with Etop. Our results indicated that Etop in-
duced a significantly higher rate of apoptosis in BID−/−
clones expressing BID-S61A/S78A than in the BID−/−
clones expressing wtBID (Figure 7A). It is interesting
that UV or TNFα treatment did not induce increased
apoptosis in the mutant BID clones (Figure 7A). West-
ern blot analysis using anti-BID antibodies indicated
that the increase in apoptosis seen in the mutant BID
clones in response to Etop was not due to either higher
levels of expression of mutant BID or to its enhanced
cleavage to tBID (Figure 7B). Thus, the mutant BID
clones were found to be more susceptible to apoptotsis
induced solely by a reagent that leads to DNA double-
strand breaks.
Discussion
In the present study, we demonstrated that double-strand
break DNA-damaging reagents induced an immediate and
transient phosphorylation of BID. In addition, we showed
that this phosphorylation was mediated by the ATM ki-
nase. Most importantly, we demonstrated that BID−/−
mouse embryonic fibroblasts failed to delay the cell cy-
cle in response to etoposide and that introduction of a
nonphosphorylatable BID mutant restored delay in the
G2 but not in the S phase. Moreover, in response to
etoposide, the mutant BID cells entered apoptosis
more readily than did the wild-type BID cells.
Previously, we suggested that full-length BID is a
player in the DNA-damage pathway, since a caspase-8
noncleavable BID mutant sensitized BID−/− mouse em-
bryonic fibroblasts to DNA damage-induced apoptosis
(Sarig et al., 2003). Our current findings demonstrate
that in MEFs, BID is important for apoptosis induced
by a variety of DNA-damaging reagents (Figure 1).
Splenocytes from BID−/− mice also display less suscep-
tibility to DNA damage, indicating that the decreased
death response to DNA damage is a general feature of
BID deficiency.
As mentioned above, BID−/− MEFs are less suscepti-
ble than BID+/+ MEFs to reagents that induce different
forms of DNA damage (Figure 1). On the other hand,
BID phosphorylation occurs only in response to re-
agents that induce double-strand breaks in DNA. Thus,
phosphorylation of BID does not seem to be critical for
its proapoptotic activity. However, lack of BID phos-
phorylation does effect the susceptibility of cells to
Cell
600Figure 5. BID−/− Mouse Embryonic Fibroblasts Fail to Arrest in the S Phase of the Cell Cycle Following Etoposide Treatment
(A) BID−/− mouse embryonic fibroblasts do not accumulate in the S and G2 phases of the cell cycle following etoposide treatment. BID+/+ or
BID−/− MEFs were either left untreated (N/T) or treated with 20 M Etop for 2 hr, rinsed, and then released into drug-free medium. At the
indicated time points, the DNA content was analyzed by flow cytometry as described in the Experimental Procedures. The actual raw data
from a representative experiment together with multiline plots generated by the ModFit LT computer software program appear in the top
panels. The dark histograms represent the percent of cells in the G1 and G2/M phases, and the hatched histograms represent the percent of
cells in S phase. The exact percentage of cells in each phase of the cell cycle is shown in the bottom three panels. The data represent the
means ±SEM of pooled results from three independent experiments.
(B) BID−/− mouse embryonic fibroblasts fail to decrease DNA synthesis following Etop treatment. BID+/+ or BID−/− MEFs were either left
untreated (N/T) or treated with 20 M Etop for 2 hr, rinsed, and then released into drug-free medium. Eight hours after release, cells were
pulse-labeled with BrdU for 30 min to determine DNA synthesis. The percentage of BrdU-positive cells was determined as described in the
Experimental Procedures. The data represent the means ±SEM of pooled results from three independent experiments.
(C) BID−/− mouse embryonic fibroblasts are not delayed in their progression from S to G2/M following Etop treatment. BID+/+ (left) or BID−/−
(right) MEFs were either left untreated (N/T) or treated with 20 M Etop for 2 hr and labeled with BrdU for 30 min. Cells were then rinsed,
incubated in fresh medium for the indicated time periods, and fixed. The percentage of BrdU-positive cells in early S phase and in late S/G2
phase was determined as described in the Experimental Procedures. The data represent the means ±SEM of pooled results from three
independent experiments.double-strand break DNA damage since BID−/− MEFs
expressing the BID-S61A/S78A mutant are more sus-
ceptible than BID−/− MEFs expressing wild-type BID to
etoposide-induced apoptosis (Figure 7). Thus, ATM-
mediated BID phosphorylation might serve as a mecha-
nism to inhibit BID’s apoptotic activity or alternatively
as a mechanism to activate a prosurvival activity of BID.
If phosphorylation were inhibiting the apoptotic activ-
ity of BID, then what would likely be the molecular basis
of such inhibition? The only known apoptotic function
of BID lies in its ability to induce the release of proapo-
ptotic factors from the mitochondria (e.g., cytochrome
c). Caspase-truncated BID (tBID) is much more efficient
than full-length BID in inducing cytochrome c release;
it would therefore be expected that ATM-mediated BID
phosphorylation inhibits the cleavage of BID, since ca-
sein kinase 1 and/or 2-mediated phosphorylation of
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tID was demonstrated to inhibit its cleavage (Desagher
t al., 2001).
However, our findings suggest that ATM-mediated
hosphorylation of BID is not related to BID cleavage,
or the following reasons: phosphorylation occurs many
ours before the activation of caspases and the onset
f apoptosis (Figure 3 and data not shown). A relatively
mall amount of BID is phosphorylated (Figure 2), and
hosphorylation occurs also in response to extremely
ow, nonapoptotic levels of DNA damage (Figure 4).
oreover, the BID-S61A/S78A mutant was not found to
e more susceptible to cleavage than was wtBID (Fig-
re 7). Lastly, though TNFα relies on the generation of
BID to induce/enhance apoptosis (Yin et al., 1999;
hao et al., 2001), the BID-S61A/S78A mutant clones
re not more susceptible to TNFα-induced apoptosis
han are the wtBID clones (Figure 7). Thus, BID phos-
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601Figure 6. BID−/− MEFs Expressing a Nonphosphorylatable BID Mutant (S61A/S78A) Do Not Accumulate in the S Phase Following Etop
Treatment
(A) BID-S61A/S78A expressed in BID−/− MEFs is not recognized by the phosphospecific Abs. BID−/− MEFs stably expressing either wtBID or
the BID-S61A/S78A mutant were treated with 20 M Etop for 1 hr, lysed, and equal amounts of protein (20 g per lane) were subjected to
SDS-PAGE, followed by Western blot analysis using either anti-BID Abs (left panel) or the phosphospecific Abs (middle and right panels). The
blots were stripped and reprobed with anti-β-actin Abs to control for loading (lower panels). * mark crossreactive bands.
(B) BID−/− MEFs stably expressing BID-S61A/S78A do not accumulate in the S phase following Etop treatment. BID−/− MEFs stably expressing
either wtBID or BID-S61A/S78A (two clones from each) were treated with 20 M Etop for 2 hr, rinsed, and then released into drug-free
medium. At the times indicated, the DNA content was analyzed by flow cytometry as described in the Experimental Procedures. The actual
raw data from a representative experiment together with multiline plots generated by the ModFit LT computer software program appear in
the top panel. The dark histograms represent the percent of cells in the G1 and G2/M phases, and the hatched histograms represent the
percent of cells in S phase. The exact percentage of cells in each phase of the cell cycle (in each of the four clones) is shown in the bottom
three panels. The data represent the means ±SEM of pooled results from three independent experiments.phorylation does not seem to serve as a mechanism to
inhibit BID’s apoptotic activity.
The results presented in Figures 5 and 6 suggest that
ATM-mediated phosphorylation of BID regulates a
novel, prosurvival function of BID related to cell cycle
arrest following DNA double-strand breaks. We first
found that etoposide induced accumulation of BID+/+
mouse embryonic fibroblasts in the S and G2 phases of
the cell cycle, whereas such an accumulation was not
observed in the BID−/− MEFs (Figure 5). Moreover, using
BrdU labeling, we have demonstrated that BID is speci-
fically required for S phase arrest. We then reintroduced
wild-type BID into BID−/− cells and found that this addi-
tion restored the ability to accumulate in the S and G2
phases of the cell cycle. Introducing the nonphos-
phorylatable BID mutant into BID−/− cells, however, re-
stored accumulation only in the G2 phase (Figure 6).
These findings imply that BID phosphorylation plays an
important role in S phase arrest.
To demonstrate the BID-dependent S phase check-point, we have used relatively high levels of etoposide,
suggesting that this function of BID is associated with
high levels of genotoxic stress in fibroblasts. On the
other hand, in myeloid and in activated T cells, this
function of BID is associated with lower levels of geno-
toxic stress (Zinkel et al., 2005 [this issue of Cell]).
Hematopoietic cells are primed to undergo cell cycle
arrest and apoptosis following treatment with DNA-
damaging reagents, whereas fibroblasts are relatively
resistant to DNA-damaging reagents and prevent prolif-
eration of mutations by entering into long-term G1 or
G2 arrest (Baus et al., 2003; Di Leonardo et al., 1994).
Thus, the activation threshold and the biological impact
of the BID-dependent S phase checkpoint function may
vary largely among different cell types.
How might the involvement of BID in S phase arrest
be related to apoptosis? Following DNA double-strand
breaks, the cell may decide to activate a survival sys-
tem (mainly through the ATM kinase, which induces cell
cycle arrest and DNA repair), or in the face of extensive
Cell
602Figure 7. BID−/− Mouse Embryonic Fibroblasts Expressing BID-
S61A/S78A Are More Susceptible to Etop-Induced Apoptosis Than
Those Expressing Wild-Type BID
(A) BID−/− MEFs stably expressing either wtBID or BID-S61A/S78A
(the four clones shown in Figure 6) were either left untreated (N/T)
or treated with Etop (50 M; 18 hr), UV (20 J/m2; 24 hr), or TNFα
(40 ng/ml together with 2 g/ml actinomycin D; 4.5 hr). Cell death
was monitored by FACScan using PI dye exclusion, as described
in the Experimental Procedures. The data represent the means
±SEM of pooled results from three independent experiments.
(B) The enhanced death obtained with the BID-S61A/S78A clones
is not due to higher expression of mutant BID or to more cleavage
to tBID. The two wtBID and two mutant BID clones were treated
either with 50 M Etop for 18 hr or with TNFα/ActD for 4.5 hr, lysed,
and equal amounts of protein (20 g per lane) were subjected to
SDS-PAGE, followed by Western blot analysis using anti-BID Abs.
For the TNFα treatment, only clones #1 are shown. The blots were
stripped and reprobed with anti-β-actin Abs to control for loading
(lower panels).
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sor irreparable damage, the cell may activate the apo-
ptotic machinery. The results presented in Figure 7 de-
monstrate that BID−/− MEFs expressing the BID-S61A/
S78A mutant are more susceptible than BID−/− MEFs
expressing wild-type BID to etoposide-induced apo-
ptosis, but not to UV- or to TNFα-induced apoptosis.
Thus, it appears that the nonphosphorylatable BID mu-
tant sensitizes BID−/− MEFs to apoptotsis induced only
by reagents that induce double-strand breaks in DNA.
These results, together with the cell cycle results
(Figures 5 and 6) suggest that the impaired ability of
the mutant BID cells to induce cell cycle arrest results
in increased sensitivity to double-strand break DNA
damage.
If BID is indeed capable of playing a prosurvival role
in the response of cells to DNA double-strand breaks,
then why are the BID−/− MEFs less sensitive than BID+/+
MEFs to apoptosis induced by etoposide and ionizing
radiation (Figure 1)? BID may play both a prosurvival
and a proapoptotic role in this pathway. Based on our
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hinding that the phosphorylation of BID occurs in re-
ponse to extremely low levels of ionizing radiation and
ncreases in an ionizing radiation dose-dependent man-
er (Figure 4), we propose that BID acts as a sentinel
f DNA double-strand breaks. BID might translate the
amage into either cell cycle arrest/DNA repair pro-
esses (at low levels of damage) or apoptosis (at high
evels of damage).
In summary, this study raises the novel possibility
hat the BH3-only BID protein, a molecule that was pre-
iously considered to be active only as a proapoptotic
actor, may also play a prosurvival role. If BID is indeed
laying both a proapoptotic and a prosurvival function
n the DNA-damage pathway, then it is an excellent
andidate to link DNA repair processes and apoptosis.
xperimental Procedures
ouse Embryonic Fibroblasts
ID−/− mice (originally kept on a mixed C57BL/6 × 129S back-
round) had been bred to wt C57BL/6 mice 12 times in order to
btain animals that are F12 on a C57BL/6 background. BID−/−
EFs were generated from the F12 mice. BID+/+ and BID−/− primary
EFs were prepared from 11- to 13-day-old embryos and main-
ained in ISCOVE’s medium containing 10% fetal bovine serum
MEF medium). ATM/ARF double-knockout and Atm+/+Arf−/− MEFs
ere obtained from Chuck J. Sherr (St. Jude Children’s Research
ospital).
ell Viability Assays
ell viability was determined by propidium iodide (PI) dye exclu-
ion. PI (25 g/ml) was added to the cells immediately prior to
nalysis by FACScan (Beckton Dickinson).
ell Cycle Assays
EFs were treated with 20 M Etop for 2 hr, rinsed, and then re-
eased into drug-free medium. Eight or twenty-four hours after re-
ease, cells were collected for fixation in methanol. Following fixa-
ion, cells were washed and resuspended in PBS with 25 g/ml PI
nd 50 g/ml RNase a half-hour before FACScan analysis. Analysis
f the cell cycle results was performed using the ModFit LT pro-
ram (Tripathi et al., 2003).
eneration of Phosphospecific Antibodies
nti-pS61 and anti-pS78 were generated in collaboration with Be-
hyl Laboratories, Inc. Briefly, immunogens were phosphorylated
ynthetic peptides, which represented portions of mouse BID
round either serine 61 or serine 78. Antibodies that were not phos-
hospecific were removed by solid phase absorption. Antibodies
hat were specific for either BID pSer61 or BID pSer78 were affinity-
urified using the phosphopeptide immobilized on solid support.
upplemental Data
upplemental Data include three figures and Supplemental Experi-
ental Procedures and can be found with this article online at
ttp://www.cell.com/cgi/content/full/122/4/593/DC1/.
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